Two studies presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting highlighted MD Anderson’s commitment to holistic patient-centered palliative and supportive care. Both studies examine ways to proactively improve comfort for patients with advanced cancers experiencing uncontrolled cancer-related symptoms.
Neuroleptic rotation for refractory agitation in cancer patients with delirium in the acute palliative...
Updated results from two MD Anderson clinical trials presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting indicate...
Findings from three studies led by researchers at MD Anderson suggest that new combination therapies are safe and effective against various...
Two studies led by MD Anderson researchers explore advancements in CAR T cell therapy for non-Hodgkin lymphomas. CAR T cell therapy is commonly used to treat large B-cell lymphoma and follicular lymphoma, which are types of non-Hodgkin lymphomas, and ongoing research focuses on minimizing toxicities and improving effectiveness, leading to better therapeutic outcomes for patients. Initial results from both studies were shared at the 2020...
Several MD Anderson-led studies at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting focus on using immunotherapy to provide...
Brian Odle has now overcome four cancer diagnoses in his life, thanks to inheriting a mutation in the TP53 gene. This inherited condition...
Julia Pitts tried all the standard treatment options with her local physicians after she was diagnosed with metastatic uterine cancer in 2015...
Mutations in the BRCA 1 or 2 genes significantly increase an individual’s risk of developing breast cancer, as well as several other cancer...
Strategies to procure high-quality core-needle biopsy (CNB) specimens are critical for making basic tissue diagnoses and for ancillary testing...